Equities

France Bed Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7840:TYO

France Bed Holdings Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,328.00
  • Today's Change-3.00 / -0.23%
  • Shares traded29.60k
  • 1 Year change+3.91%
  • Beta0.5241
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

France Bed Holdings Co Ltd is a Japan-based company mainly engaged in medical service business and interior healthy business. The Company operates through two business segments. The Medical Service segment is engaged in manufacturing, purchase, leasing, retail and wholesale of nursing beds and welfare equipment, as well as linen supply for hospitals and hotels. The Interior Healthy segment is engaged in manufacturing, purchase and wholesale of bed, furniture, bedroom product and healthcare equipment, as well as the door-to-door selling, advertising and exhibition operation. The Company is also involved in the real estate leasing business.

  • Revenue in JPY (TTM)60.57bn
  • Net income in JPY2.67bn
  • Incorporated2004
  • Employees1.81k
  • Location
    France Bed Holdings Co Ltd6F, Shinjuku Square Tower6-22-1, NishishinjukuSHINJUKU-KU 163-1105JapanJPN
  • Phone+81 367415501
  • Fax+81 367415501
  • Websitehttp://www.francebed-hd.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Findex Inc5.90bn1.18bn24.56bn311.0019.904.3116.324.1646.3946.39232.45214.020.94678.734.9918,984,330.0019.2116.4821.5419.1963.7758.1820.2916.354.18--0.0034.7312.516.419.7518.41-4.0213.40
Kusurinomadoguchi Inc11.58bn3.10bn29.39bn484.009.433.096.462.54274.21274.211,023.48838.470.7189--3.1923,926,840.0019.64--34.71--56.56--27.32------0.0872--28.41--133.66------
Mizuho Medy Co Ltd9.67bn2.81bn34.18bn187.0012.162.0311.143.54147.57147.57507.44884.420.49991.172.8851,689,840.0014.5429.3716.0335.7568.7374.8529.0935.778.01--0.0037.844.0012.20-0.032833.97-17.0647.14
Rion Co Ltd27.94bn2.98bn34.85bn1.01k11.671.058.011.25241.73241.732,267.252,682.200.71751.673.8927,692,170.007.656.578.727.6249.5350.1110.669.273.55--0.0028.398.365.377.829.9520.048.61
Nippon Care Supply Co., Ltd.34.10bn2.17bn39.90bn1.45k17.632.134.271.17139.36139.362,194.671,155.761.26101.8030.3523,453,350.008.007.3711.529.8036.4536.776.356.340.7615--0.091359.8011.9410.8813.573.7013.338.76
Cyberdyne Inc4.20bn-202.00m40.96bn211.00--1.5995.259.74-0.9568-0.956819.91187.540.08531.768.4519,924,170.00-0.5092-1.36-0.5198-1.3860.2357.96-5.97-20.8013.31--0.011--0.68919.5960.91---5.51--
Win-Partners Co Ltd86.20bn2.19bn41.24bn630.0017.581.6716.880.478576.9076.903,034.52811.941.9123.334.84136,819,400.004.844.298.977.9211.9512.402.542.591.66--0.0068.005.644.759.981.5233.839.52
France Bed Holdings Co Ltd60.57bn2.67bn46.25bn1.81k19.091.135.820.763669.7269.721,599.641,173.360.90313.036.3533,427,150.003.984.194.995.6554.9553.374.414.781.92--0.245546.932.382.93-6.0014.15-2.507.39
Medikit Co Ltd23.19bn3.09bn47.80bn989.0014.290.96269.632.06210.69210.691,583.813,126.900.44363.124.4623,448,020.005.905.706.666.3038.6039.3713.3113.845.04--0.000241.813.222.54-1.820.854821.5712.47
Japan Eyewear Holdings Co Ltd17.99bn4.22bn48.36bn580.0011.612.848.072.69172.64172.64736.69704.930.47411.8016.5631,022,410.0011.13--12.75--79.15--23.48--0.785318.060.4966--23.20--80.15------
Nagaileben Co Ltd16.69bn2.48bn55.42bn501.0022.361.4320.113.3280.6280.62544.001,263.590.38981.324.2033,321,640.005.786.906.137.4339.3743.3514.8418.6810.68--0.0067.123.48-0.097-8.81-5.8216.970.00
TAUNS Laboratories Inc14.58bn3.98bn58.20bn316.0014.923.6412.383.9936.6636.66136.75150.350.42710.85793.2746,129,040.0011.65--16.30--65.82--27.28--0.848643.440.557--1.05--9.38------
Kitazato Corp10.71bn3.89bn61.36bn86.0015.783.3315.085.7397.2397.23267.65460.350.57241.779.11--20.79--22.38--67.40--36.33--9.24--0.00--2.20---4.63------
Shofu Inc38.97bn4.25bn65.13bn1.41k15.301.4212.021.67118.98118.981,092.321,279.850.75741.239.8127,577,490.008.287.279.278.2459.4558.4110.949.752.72--0.0032.9910.318.1918.1143.72-3.1930.39
Data as of Feb 06 2026. Currency figures normalised to France Bed Holdings Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

9.82%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 07 Jan 2026937.78k2.70%
Nomura Asset Management Co., Ltd.as of 14 Nov 2025879.90k2.53%
Amova Asset Management Co., Ltd.as of 09 Jan 2026413.90k1.19%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2025395.60k1.14%
Dimensional Fund Advisors LPas of 08 Jan 2026372.80k1.07%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 2026177.90k0.51%
Mellon Investments Corp.as of 09 Jan 202668.60k0.20%
BlackRock Japan Co. Ltd.as of 08 Jan 202664.30k0.19%
Norges Bank Investment Managementas of 30 Jun 202556.20k0.16%
Charles Schwab Investment Management, Inc.as of 08 Jan 202644.92k0.13%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.